Detalhe da pesquisa
1.
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.
Breast Cancer Res Treat
; 142(2): 389-98, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166281
2.
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.
BMC Pharmacol
; 11: 7, 2011 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21771338
3.
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.
Mol Endocrinol
; 22(2): 263-72, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17932106
4.
Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.
Cancer Res
; 69(8): 3589-96, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351835